Detalhe da pesquisa
1.
Study on the Optimal Dose of Irinotecan for Patients with Heterozygous Uridine Diphosphate-Glucuronosyltransferase 1A1 (UGT1A1).
Biol Pharm Bull
; 42(11): 1839-1845, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31685767
2.
Characteristics of and risk factors for interstitial lung disease induced by chemotherapy for lung cancer.
Ann Pharmacother
; 49(4): 398-404, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25565405
3.
A novel targeting therapy of malignant mesothelioma using anti-podoplanin antibody.
J Immunol
; 190(12): 6239-49, 2013 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23690472
4.
Pemetrexed-Induced Rash May Be Prevented by Supplementary Corticosteroids.
Biol Pharm Bull
; 38(11): 1752-6, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26521826
5.
Surfactant protein A suppresses lung cancer progression by regulating the polarization of tumor-associated macrophages.
Am J Pathol
; 182(5): 1843-53, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23499372
6.
Two Cases of Mycobacterium shinjukuense Pulmonary Disease With a Long-Term Response to Treatment With Clarithromycin, Rifampicin, and Ethambutol.
Cureus
; 16(1): e52888, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38406085
7.
A Case of Autoimmune Pulmonary Alveolar Proteinosis With Predominantly Peripheral Opacities Diagnosed by Transbronchial Lung Biopsy.
Cureus
; 16(2): e54261, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38496134
8.
SU6668, a multiple tyrosine kinase inhibitor, inhibits progression of human malignant pleural mesothelioma in an orthotopic model.
Respirology
; 17(6): 984-90, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22574723
9.
Intensification therapy with anti-parathyroid hormone-related protein antibody plus zoledronic acid for bone metastases of small cell lung cancer cells in severe combined immunodeficient mice.
Mol Cancer Ther
; 8(1): 119-26, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19139120
10.
HM1.24 (CD317) is a novel target against lung cancer for immunotherapy using anti-HM1.24 antibody.
Cancer Immunol Immunother
; 58(6): 967-76, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18979097
11.
A bone metastasis model with osteolytic and osteoblastic properties of human lung cancer ACC-LC-319/bone2 in natural killer cell-depleted severe combined immunodeficient mice.
Oncol Res
; 17(11-12): 581-91, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19806789
12.
Follistatin suppresses the production of experimental multiple-organ metastasis by small cell lung cancer cells in natural killer cell-depleted SCID mice.
Clin Cancer Res
; 14(3): 660-7, 2008 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18245525
13.
The clinical features of older patients with lung cancer in comparison with their younger counterparts.
Respir Investig
; 57(1): 40-48, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30448243
14.
Lysophosphatidic acid stimulates the proliferation and motility of malignant pleural mesothelioma cells through lysophosphatidic acid receptors, LPA1 and LPA2.
Cancer Sci
; 99(8): 1603-10, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18754873
15.
Novel dual targeting strategy with vandetanib induces tumor cell apoptosis and inhibits angiogenesis in malignant pleural mesothelioma cells expressing RET oncogenic rearrangement.
Cancer Lett
; 265(1): 55-66, 2008 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-18364248
16.
A multicenter, open-label, phase II trial of S-1 plus carboplatin in advanced non-small cell lung cancer patients with interstitial lung disease.
Lung Cancer
; 125: 93-99, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30429044
17.
Phase II study of tailored S-1 monotherapy with a 1-week interval after a 2-week dosing period in elderly patients with advanced non-small cell lung cancer.
Respir Investig
; 56(1): 80-86, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29325686
18.
Levels of soluble vascular endothelial growth factor receptor 1 are elevated in the exudative pleural effusions.
J Med Invest
; 54(1-2): 146-53, 2007 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-17380026
19.
Analysis of acute exacerbation of interstitial lung disease associated with chemotherapy in patients with lung cancer: A feasibility of S-1.
Respir Investig
; 55(2): 145-152, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28274530
20.
Reveromycin A inhibits osteolytic bone metastasis of small-cell lung cancer cells, SBC-5, through an antiosteoclastic activity.
Clin Cancer Res
; 11(24 Pt 1): 8822-8, 2005 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16361571